VICAL INC Uncategorized Contracts & Agreements

31 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Plan of Dissolution of Fresh Tracks Therapeutics, Inc
VICAL INC
Biotechnology
DE
2023
Second Amendment to Rights Agreement, dated as of July 21, 2023, by and among Fresh Tracks Therapeutics, Inc., Brickell Subsidiary, Inc., and Bodor Laboratories, Inc
VICAL INC
Biotechnology
FL
2023
Letter Agreement, dated as of May 4, 2023, by and between Fresh Tracks Therapeutics, Inc. and BRE-BMR Flatiron VII LLC (f/k/a GPIF 5777 Flatiron LLC and BMC Properties, LLC)
VICAL INC
Biotechnology
2023
Description of the Registrants Securities Registered Pursuant to Section 12 of the Exchange Act
VICAL INC
Biotechnology
2023
Amendment to Rights Agreement, dated as of November 10, 2022, by and among Fresh Tracks Therapeutics, Inc., Brickell Subsidiary, Inc. and Bodor Laboratories, Inc
VICAL INC
Biotechnology
FL
2022
Rights Agreement, dated as of May 3, 2022, by and among Brickell Biotech, Inc., Brickell Subsidiary, Inc., and Bodor Laboratories, Inc
VICAL INC
Biotechnology
FL
2022
Description of the Registrants Securities Registered Pursuant to Section 12 of the Exchange Act
VICAL INC
Biotechnology
2022
Description of the Registrants Securities Registered Pursuant to Section 12 of the Exchange Act
VICAL INC
Biotechnology
2021
Letter Agreement, dated as of September 3, 2020, by and between Brickell Biotech, Inc. and Kaken Pharmaceutical Co., Ltd
VICAL INC
Biotechnology
2020
Brickell Biotech, Inc. Letter Agreement, dated July 10, 2018 by and between Brickell Biotech Inc. and Jose Breton
VICAL INC
Biotechnology
CO
2019
Right of First Negotiation Agreement, as amended, dated March 31, 2015, by and between Brickell Biotech, Inc. and Kaken Pharmaceutical Co., Ltd
VICAL INC
Biotechnology
CO
2019
Form of Lock-Up Agreement, dated June 2, 2019, by each of the parties named in each agreement therein
VICAL INC
Biotechnology
2019
Form of Support Agreement, dated June 2, 2019, by and between the Company and each of the parties named in each agreement therein
VICAL INC
Biotechnology
DE
2019
AMENDMENT No.1
VICAL INC
Biotechnology
2015
10390 Pacific Center Court, San Diego, CA92121-43408586461100, FAX: 8586461150www.vical.com
VICAL INC
Biotechnology
2013
EXHIBIT A OPTION TERMS
VICAL INC
Biotechnology
2013
Vical Incorporated Non-Employee DirectorCompensation Policy
VICAL INC
Biotechnology
2010
Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020
VICAL INC
Biotechnology
NY
2009
FIRST AMENDMENT TO
VICAL INC
Biotechnology
CA
2007
VICAL INCORPORATED 10390 Pacific Center Court
VICAL INC
Biotechnology
2006
VICAL INCORPORATED 10390 Pacific Center Court
VICAL INC
Biotechnology
2006
VICAL INCORPORATED 10390 Pacific Center Court
VICAL INC
Biotechnology
2006
4,704,000 Shares
VICAL INC
Biotechnology
NY
2005
VICAL INCORPORATED 10390 Pacific Center Court San Diego, CA 92121-4340 April 15, 2005
VICAL INC
Biotechnology
2005
SECURITYAGREEMENT (Securities) Dated as of March 19, 2004
VICAL INC
Biotechnology
GA
2004
VICAL INCORPORATED 10390 Pacific Center Court San Diego, CA 92121-4340 March 15,2004
VICAL INC
Biotechnology
2004
3,379,000 Shares VICAL INCORPORATED
VICAL INC
Biotechnology
NY
2004
SOLICITATION
VICAL INC
Biotechnology
2004
VICAL INCORPORATED 9373 Towne Centre Drive Suite 100 San Diego, CA 92121 March 10, 2003
VICAL INC
Biotechnology
2003
to the Research, Option and LicenseAgreement dated September 29, 1994
VICAL INC
Biotechnology
2003
INDEMNITY AGREEMENT
VICAL INC
Biotechnology
DE
2003